- Geen gegevens
Nederlands
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Laser plays an important role in fields such as photonic chips, laser displays, and in vehicle radars. Organic materials have advantages such as molecular diversity, energy level richness, heterogeneous compatibility, and ease of processing. They have significant advantages in the construction of high-performance and multifunctional lasers and are expected to further innovate laser technology and ...
In recent years, the secondary battery equipment sector in South Korea has been hit by a wave of disruption, with demand temporarily stagnant and stock prices struggling to gain support. Especially for Youil Energy Tech, a manufacturer of secondary battery equipment, as the company is a latecomer to the laser equipment market, its sales cost burden is relatively high. It is expected that in the fu...
As humanity enters a new era of computing, new small tools are needed to enhance the interaction between photons and electrons, and integrate electrical and photon functions at the nanoscale. Researchers have created a novel III-V semiconductor nanocavity that can limit light below the so-called diffraction limit, which is an important step towards achieving this goal.In the journal Optical Materi...
Recently, NUBURU, a supplier of high-power and high brightness industrial blue laser technology in the United States, announced that it has reached bridge loan agreements ("bridge loans" or "bridge financing") with existing and new institutional investors.The principal of this bridge financing is $5.5 million, aimed at providing funding for the company until it obtains long-term credit financing,...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...